logo
Plus   Neg
Share
Email

Sorrento Board Rejects Acquisition Proposal - Quick Facts

Sorrento Therapeutics, Inc. (SRNE) said its Board has unanimously rejected the acquisition proposal from a private equity fund as the offer significantly undervalues Sorrento. The non-binding proposal received on January 9, 2020 was valued up to $7.00 per share.

In November 2019, Sorrento rejected term sheet proposal submitted by two biopharmaceutical companies, to acquire all of the issued and outstanding shares of the company for between $3.00 and $5.00 per share in cash.

Sorrento said its management continues to execute on the core drug development and to pursue multiple potential strategic alliances and transactions.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter could face a fine of up to $250 million from the U.S. Federal Trade Commission regarding its use of phone numbers and email addresses to target advertisements. Lord & Taylor joined the growing list of U.S. retailers who filed for bankruptcy amid the coronavirus pandemic. Lord & Taylor, one of the oldest department store chains in the U.S., filed for bankruptcy protection in the Eastern Court of Virginia on Sunday. The company operated 38 stores that have remained temporarily closed since March this year due to the pandemic. Thomson International Inc. is recalling Red, Yellow, White, and Sweet Yellow Onions for potential contamination with Salmonella, according to a statement by the U.S. Food and Drug Administration or FDA. The onions are in distribution since May 1, 2020. They were sold to wholesalers, restaurants, and retail stores in all 50 U.S. states, the District of Columbia and Canada.
Follow RTT